Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
about
Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels.Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyPotentiating effects of GHRH analogs on the response to chemotherapy.Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108]GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.Cancer treatment using peptides: current therapies and future prospectsShrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonistAntagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersPowerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108.Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesBombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.
P2860
Q34101055-F520FDD0-45F3-4E9D-970A-A962C84694D0Q34781112-D2134446-BD00-454D-9C1A-8769A0AF8749Q35565027-8BD3852E-9449-438B-9616-20A87E30A222Q36236479-18620732-8F01-4857-B84A-CCA7225BB26CQ36472257-1E38CFC8-19F5-4E23-8BCC-D81A18E32EA5Q36515785-0F2F3E4F-F4F5-4BED-9F8C-CC58301BDD47Q36617058-2A6D805B-7FBB-427E-93EE-89C500C05297Q36862773-7BD84504-67D7-43D1-BBFF-8D0E022C18D0Q37093547-A1580471-5272-403A-9411-EB78D8BF91B2Q38216009-A28A3F06-A0EC-419F-B911-04AF159A4E97Q38776596-9A94F516-78F4-4922-AB59-B2C4BFEDFBA2Q39201247-BBDF1566-4DF2-4DF1-AE8C-ECD4E28C0214Q39378866-FE7E3BB3-E4A6-4A04-9084-DD199BB35FF7
P2860
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combination of gastrin-releasi ...... man experimental colon cancers
@ast
Combination of gastrin-releasi ...... man experimental colon cancers
@en
type
label
Combination of gastrin-releasi ...... man experimental colon cancers
@ast
Combination of gastrin-releasi ...... man experimental colon cancers
@en
prefLabel
Combination of gastrin-releasi ...... man experimental colon cancers
@ast
Combination of gastrin-releasi ...... man experimental colon cancers
@en
P2093
P2860
P356
P1433
P1476
Combination of gastrin-releasi ...... man experimental colon cancers
@en
P2093
Andreas Stadlmayr
Awtar Krishan
Christian Datz
Elmar Aigner
Florian Hohla
Luca Szalontay
Norman L Block
Roberto Perez
Stefan Buchholz
Stephan Seitz
P2860
P304
P356
10.4161/CC.20900
P577
2012-07-01T00:00:00Z